Pharmaceutical / Drug Definition :
Antipsychotic effects may occur through antagonism of dopamine D2 and serotonin 5-HT2 receptors. Other effects may result partly from antagonism of other receptors, such as histamine H1 and alpha1-adrenergic receptors.
In the United States, Quetiapine Fumarate is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Quetiapine Fumarate.
FDA Label Requirements and Exceptions
FDA Import Information
Quetiapine Fumarate (Quetiapine Fumarate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Quetiapine Fumarate (Quetiapine Fumarate Suppliers)
- Processors Quetiapine Fumarate
- Repackers Quetiapine Fumarate
- Relabelers Quetiapine Fumarate
- Exporters Quetiapine Fumarate
- Importers Quetiapine Fumarate
For more information about Quetiapine Fumarate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.